New Horizon Aircraft Swings to $26.5M Loss as R&D Spending Surges in Q3 2026
New Horizon Aircraft, an aerospace development company, posted a net loss of $26.5 million for the nine months ending February 28, 2026, a sharp reversal from an $11.8 million profit in the prior-year period. Operating expenses more than doubled to $18.6 million.
New Horizon Aircraft Ltd., an aerospace development company, reported a net loss of $26.5 million for the nine months ending February 28, 2026, reversing a net income of $11.8 million in the same period a year earlier. The company reported no revenue for either period. Read more earnings reports.
Operating expenses surged to $18.6 million for the nine-month period, up 95% from $9.5 million in the prior year. Research and development spending drove the increase, climbing to $9.6 million from $1.2 million, an eightfold jump as the company ramped up development activity.
For the three months ending February 28, 2026, New Horizon posted a net loss of $6.9 million compared to a loss of $4.9 million in the same quarter last year. R&D expenses for the quarter reached $4.3 million, nearly ten times the $443,000 spent in the prior-year quarter.
Cash Position Strengthens Despite Losses
The company closed the period with $19.7 million in cash and cash equivalents, up sharply from $7.5 million at the end of May 2025. Total assets reached $21.9 million as of February 28, 2026, compared to $8.4 million nine months earlier.
Cash from financing activities totaled $24.7 million for the nine-month period, reflecting capital raised during the year. Cash used in operations was $11.8 million, compared to $6.8 million in the prior-year period. Common shares outstanding increased to 44.96 million from 32.33 million at the start of fiscal 2026.
Equity and Liabilities
Stockholders' equity stood at $14.1 million as of February 28, 2026, up from $2.6 million at May 31, 2025. Retained deficit widened to $35.9 million from $9.5 million. The common stock value on the balance sheet increased to $111.9 million from $84.6 million.
Total liabilities rose to $7.8 million from $5.8 million. Current liabilities edged up to $1.4 million from $1.3 million, while accounts payable climbed to $1.1 million from $679,000.
Per-Share Results
The company reported a basic loss per share of $0.64 for the nine months ending February 28, 2026, compared to earnings of $0.49 per share in the prior-year period. For the third quarter alone, the loss per share was $0.16 versus $0.17 a year earlier.
| Period | Q3 2026 | Q3 2025 | 9M 2026 | 9M 2025 |
|---|---|---|---|---|
| Net Income (Loss) | -$6.9M | -$4.9M | -$26.5M | $11.8M |
| Operating Expenses | $7.6M | $3.6M | $18.6M | $9.5M |
| R&D Expenses | $4.3M | $443K | $9.6M | $1.2M |
| EPS (Basic) | -$0.16 | -$0.17 | -$0.64 | $0.49 |
| Cash & Equivalents | $19.7M | — | $19.7M | $9.2M |
The company is incorporated in Canada and qualifies as a non-accelerated filer and small business under securities regulations.